Epidemiology of systemic lupus erythematosus in Asia

Lupus

Volumn 19, Issue 12, 2010, Pages 1365-1373

  Osio Salido, E ^a   Manapat Reyes, H ^a  

^a UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

Author keywords

Asia; clinical manifestations; epidemiology; incidence; prevalence; systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY;

ANEMIA; ARTHRITIS; BANGLADESH; CHINA; CLINICAL ASSESSMENT; CLINICAL FEATURE; HEMOLYTIC ANEMIA; HONG KONG; HUMAN; INCIDENCE; INDIA; INDONESIA; INFLAMMATION; IRAN; IRAQ; ISRAEL; JAPAN; JORDAN; KUWAIT; LEBANON; LEUKOPENIA; LYMPHOCYTOPENIA; MALAYSIA; MEDLINE; MOUTH ULCER; MUSCULOSKELETAL DISEASE; NEPHRITIS; OMAN; PAKISTAN; PHILIPPINES; PHOTOSENSITIVITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SAUDI ARABIA; SEX DIFFERENCE; SINGAPORE; SOUTH KOREA; SRI LANKA; SYSTEMIC LUPUS ERYTHEMATOSUS; TAIWAN; THAILAND; THROMBOCYTOPENIA; UNITED ARAB EMIRATES; VIET NAM;

ASIA; HUMANS; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREVALENCE;

EID: 78649728804     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203310374305     Document Type: Review

References (64)

1. Wallace DJ, Hahn BH Dubois' Lupus Erythematosus, 7 th edn. Philadelphia, Pennsylvania: Lippincott Williams & Wilkins ; 2007.
2. Asia http://www.en.wikipedia.org/wiki/Asia (consulted 19 September 2009 ).
3. Farooqi A., Gibson T. Prevalence of the major rheumatic disorders in the adult population of North Pakistan. Br J Rheumatol 1998 ; 37: 491-495.
4. Dai SM, Han XH, Zhao DB, Shi YQ, Liu Y., Meng JM Prevalence of rheumatic symptoms, rheumatoid arthritis, ankylosing spondylitis, and gout in Shanghai, China: a COPCORD Study. J Rheumatol 2003 ; 30: 2245-2251.
5. Davatchi F., Jamshidi A-R., Banihashemi AT, et al. WHO-ILAR COPCORD Study (Stage 1, Urban Study) in Iran. J Rheumatol 2008 ; 35: 1384-1390.
6. Veerapen K., Wigley RD, Valkenburg H. Musculoskeletal pain in Malaysia: a COPCORD Survey. J Rheumatol 2007 ; 34: 207-213.
7. Haq SA, Darmawan J., Islam MN, et al. Prevalence of rheumatic diseases and associated outcomes in rural and urban communities in Bangladesh: a COPCORD study. J Rheumatol 2005 ; 32: 348-353.
8. Chopra A., Patil J., Billempelly V., Relwani J., Tandle HS Prevalence of rheumatic diseases in a rural population in western India: a WHO-ILAR COPCORD Study. J Assoc Physicians India 2001 ; 49: 240-246.
9. Dans LF, Tankeh-Torres S., Amante CM, Penserga EG The prevalence of rheumatic diseases in a Filipino urban population: a WHO-ILAR COPCORD Study. World Health Organization. International League of Associations for Rheumatology. Community Oriented Program for the Control of the Rheumatic Diseases. J Rheumatol 1997 ; 24: 1814-1819.
10. Wigley R., Manahan L., Muirden KD, et al. Rheumatic disease in a Philippine village II: a WHO-ILAR-APLAR COPCORD study, phases II and III. Rheumatol Int 1991 ; 11: 157-161.
11. Chaiamnuay P., Darmawan J., Muirden KD, Assawatanabodee P. Epidemiology of rheumatic disease in rural Thailand: a WHO-ILAR COPCORD study. J Rheumatol 1998 ; 25: 1382-1387.
12. Minh Hoa TT, Darmawan J., Chen SL, Van Hung N., Thi Nhi C., Ngoc An T. Prevalence of the rheumatic diseases in urban Vietnam: a WHO-ILAR COPCORD study. J Rheumatol 2003 ; 30: 2252-2256.
13. Chou CT, Pei L., Chang DM, Lee CF, Schumacher HR, Liang MH Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences. J Rheumatol 1994 ; 21: 302-306.
14. Al-Arfaj AS, Al-Balla SR, Al-Dalaan AN, et al. Prevalence of systemic lupus erythematosus in central Saudi Arabia. Saudi Med J 2002 ; 23: 87-89.
15. Zeng QY, Chen R., Darmawan J., Xiao ZY, Chen SB, Wigley R., et al. Arthritis Res Ther 2008 ; 10: R17.
16. Malaviya AN, Singh RR, Singh YN, Kapoor SK, Kumar A. Prevalence of systemic lupus erythematosus in India. Lupus 1993 ; 2: 115-118.
17. Mok CC, Lau CS Lupus in Hong Kong Chinese. Lupus 2003 ; 12: 717-722.
18. Edwards CJ Lupus in Singapore. Lupus 2001 ; 10: 889-891.
19. Wang F., Wang CL, Tan CT, Manivasagar M. Systemic lupus erythematosus in Malaysia: a study of 539 patients and comparison of prevalence and disease expression in different racial and gender groups. Lupus 1997 ; 6: 248-253.
20. Al-Rawi Z., Al-Shaarbaf H., Al-Raheem E., Khalifa SJ Clinical features of early cases of systemic lupus erythematosus in Iraqui patients. Br J Rheumatol 1983 ; 22: 165-171.
21. Phan JC, Bush TM, Donald F., Ward M. Clinical and laboratory features of patients of Vietnamese descent with systemic lupus erythematosus. Lupus 1999 ; 8: 521-524.
22. Iseki K., Miyasato F., Oura T., Uehara H., Nishime, Fukiyama K. An epidemiologic analysis of end-stage lupus nephritis. Am J Kidney Dis 1994 ; 23: 547-554.
23. Nakae K. A nationwide epidemiological survey on diffuse collagen diseases; estimation of prevalence rate in Japan. Amsterdam, The Netherlands: Elsevier ; 1987.
24. Fukase M. The epidemiology of systemic lupus erythematosus in Japan. Baltimore, Maryland: University Park Press ; 1980.
25. Mimori T. Systemic lupus erythematosus (in Japanese). In: Sugimoto T, Obata M, Mizuno Y (eds), Internal medicine, 8 th edn. Tokyo, Japan: Asakurashoten ; 2003. p. 1232-1238.
26. Serdula MK, Rhoads GG Frequency of systemic lupus erythematosus in different ethnic groups in Hawaii. Arthritis Rheum 1979 ; 22: 328-333.
27. Mok CC, To CH, Ho LY, Yu KL Incidence and mortality of systemic lupus erythematosus in a Southern Chinese population, 2000-2006. J Rheumatol 2008 ; 35: 1978-1982.
28. Chandrasekaran AN Clinical and immunological profile of SLE in India (abstract). In: Feng PH (ed) Proceeding of the XIXth ILAR Congress of Rheumatology. Singapore: Communication Consultants, 1997, 156-164.
29. Navarra SV, King JO An overview of clinical manifestations and survival of systemic lupus erythematosus patients in Asia. APLAR. J Rheumatol 2006 ; 9: 336-341.
30. Chun BC, Bae SC Mortality and cancer incidence in Korean patients with systemic lupus erythematosus: results from the Hanyang lupus cohort in Seoul, Korea. Lupus 2005 ; 14: 635-638.
31. Wang J., Yang S., Chen JJ, et al. Systemic lupus erythematosus: a genetic epidemiology study of 695 patients from China. Arch Dermatol Res 2007 ; 298: 485-491.
32. Feng PH, Boey ML Systemic lupus erythematosus in Chinese: the Singapore experience. Rheumatol Int 1982 ; 2: 151-154.
33. Ho HJ, Kong KO, Thong YH, et al. Early Oriental Lupus Cohort - a prospective follow-up of newly diagnosed lupus patients of oriental ethnicity (abstract). In: Proceedings of the 11th Asia Pacific League of Associations for Rheumatology Congress, Korea, 2004, p. 0035.
34. Parivisutt L., Nilganuwong S. SLE in Thailand-a study of 1378 cases (abstract). In: Proceedings of the ILAR Congress of Rheumatology Singapore. Singapore: Communication Consultants 1997, 150-151.
35. Wongchinsri J., Charuwat P., Sukonthapirom P., et al. Clinical manifestations of SLE patient in Nopparat Rajathanee Hospital from July 2001 to April 2004 (abstract). In: Proceedings of the 11th Asia Pacific League of Associations for Rheumatology Congress, Korea 2004, p. 0033.
36. Nantiruj K. SLE: clinical experience in Thai patients (abstract). Lupus 2007 ; S16: 33-34.
37. Salido EO, Gumban MM Clinical characteristics of Filipino lupus patients seen over 30 years at the Philippine General Hospital (abstract). Lupus 2007 ; S16: 117.
38. Villamin CAC, Navarra SV Clinical manifestations and clinical syndromes of Filipino patients with systemic lupus erythematosus. Mod Rheumatol 2008 ; 18: 161-164.
39. Tan BE, Ong SG, Jamaiyah H., et al. Systemic lupus erythematosus in a tertiary rheumatology centre in Malaysia (abstract). APLAR. J Rheumatol 2006 ; 9 (Suppl 1). A21 - A278.
40. Kasjimir YI, Nasution AR Clinical manifestations of systemic lupus erythematosus: Indonesia experience, a retrospective multi-centre study (abstract). Ryumachi 1997 ; 37: 333.
41. Malaviya AN, Chandrasekaran AN, Kumar A., Shamar PN Systemic lupus erythematosus in India. Lupus 1997 ; 6: 690-700.
42. Rabbani MA, Siddiqui BK, Tahir MH, et al. Systemic lupus erythematosus in Pakistan. Lupus 2004 ; 13: 820-825.
43. Galapatthy P., Wazeel AN, Nanayakkara S., Sheriff R. Clinical features of systemic lupus erythematosus in Sri Lankan patients: results from a lupus clinic (abstract). Ceylon Med J 2000 ; 45: 162-165.
44. Nazarinia MA, Ghaffarpasand F., Shamsdin A., Karimi AA, Abbasi N., Amiri A. Systemic lupus erythematosus in the Fars Province of Iran. Lupus 2008 ; 17: 221-227.
45. AlSaleh J., Jassim V., ElSayed M., Saleh N., Harb D. Clinical and immunological manifestations in 151 SLE patients living in Dubai. Lupus 2008 ; 17: 62-66.
46. Al-Attia HM Clinicolaboratory profile of 33 Arabs with systemic lupus erythematosus. Postgrad Med J 1996 ; 72: 677-679.
47. Heller T., Ahmed M., Siddiqqi A., Wallrauch C., Bahlas S. Systemic lupus erythematosus in Saudi Arabia: morbidity and mortality in a multiethnic population. Lupus 2007 ; 16: 908-914.
48. Al-Rayes H., Al-Swailem R., Arfin M., Sobki S., Rizvi S., Tariq M. Systemic lupus erythematosus and infections: a retrospective study in Saudis (abstract). Lupus 2007 ; 16: 755-763.
49. Alballa SR Systemic lupus erythematosus in Saudi patients. Clin Rheumatol 1995 ; 14: 342-346.
50. Habib GS, Saliba WR Systemic lupus erythematosus among Arabs. Isr Med Assoc J 2002 ; 4: 690-693.
51. Uthman I., Nasr F., Kassak K., Masri AF Systemic lupus erythematosus in Lebanon. Lupus 1999 ; 8: 713-715.
52. Al-Jarallah K., Al-Awadi A., Siddiqui H., et al. Systemic lupus erythematosus in a Kuwait hospital-based study. Lupus 1998 ; 7: 34-38.
53. Al-Maini MH, El-Ageb EM, Al-Wahaibi SS, Al-Farsi Y., Richens ER Demographic, autoimmune, and clinical profiles of patients with systemic lupus erythematosus in Oman. Rheumatol Int 2003 ; 23: 186-191. (Epub 2 April 2003 ).
54. Karadsheh MF, Nimri FA, Ajlouni YM, Dneibat WA, Karadsheh RF The characteristics of systemic lupus erythematosus. A study in a general hospital. Saudi Med J 2000 ; 21: 282-286.
55. Samanta A., Feehally J., Roy S., Nichol FE, Sheldon PJ, Walls J. High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis 1991 ; 50: 490-492.
56. Hopkinson N. Epidemiology of systemic lupus erythematosus. Ann Rheum Dis 1992 ; 51: 1292-1294.
57. Danchenko N., Sattia JA, Anthony MS Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 2006 ; 15: 308-318.
58. Uramoto KM, Michet Jr CJ, Thumboo J., et al. Trends in the incidence and mortality of systemic lupus erythematosus, 1950 to 1992. Arthritis Rheum 1999 ; 42: 46-50.
59. Blanco FJ, De la Mata J., Gomez-Reino JJ, et al. Manifestaciones clinicas y serologicas de 307 pacientes españoles con lupus eritematososistemico. Comparacion con otros grupos etnicos. Rev Clin Exp 1995 ; 195: 534-540.
60. Vila LM, Mayor AM, Valenti AH, Garcia Sobera M., Vila S. Clinical and immunological manifestations in 134 Puerto Rican patients with systemic lupus erythematosus. Lupus 1999 ; 8: 279-286.
61. Cervera R., Khamashta MA, Font J., et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 1993 ; 72: 113-124.
62. Pistiner M., Wallace DJ, Nessim S., et al. Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum 1991 ; 21: 55-64.
63. Alarcon GS, McGwin G., Bastian HM, et al LUMINA Study Group. Systemic lupus erythematosus in three ethnic groups. VIII. Predictors of early mortality in the LUMINA cohort. Arthritis Care Res 2001 ; 45: 191-202.
64. Pons-Estel BA, Catoggio LJ, Cardiel MH, et al. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus. Medicine 2003 ; 83: 1-17.